Early research (Phase 1)Study completedNCT05050474
What this trial is testing
Booster Immunization Study of Recombinant SARS-CoV-2 Fusion Protein Vaccine (V-01)
Who this might be right for
COVID19
Livzon Pharmaceutical Group Inc. 43
Showing 20 of 0 results